[go: up one dir, main page]

BRPI0819338A2 - Preparações, métodos e kits úteis para o tratamento de tosse - Google Patents

Preparações, métodos e kits úteis para o tratamento de tosse

Info

Publication number
BRPI0819338A2
BRPI0819338A2 BRPI0819338-0A BRPI0819338A BRPI0819338A2 BR PI0819338 A2 BRPI0819338 A2 BR PI0819338A2 BR PI0819338 A BRPI0819338 A BR PI0819338A BR PI0819338 A2 BRPI0819338 A2 BR PI0819338A2
Authority
BR
Brazil
Prior art keywords
kits
useful
methods
cough preparations
cough
Prior art date
Application number
BRPI0819338-0A
Other languages
English (en)
Inventor
Stephen Andras Kovacs
Jeffrey Alan Sargent
Helen Rochelle Kemp
Kristin Rhedrick Williams
Mary Lynn Jump
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BRPI0819338A2 publication Critical patent/BRPI0819338A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0819338-0A 2007-11-21 2008-11-20 Preparações, métodos e kits úteis para o tratamento de tosse BRPI0819338A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US388607P 2007-11-21 2007-11-21
US2854708P 2008-02-14 2008-02-14
PCT/IB2008/054886 WO2009066262A1 (en) 2007-11-21 2008-11-20 Preparations, methods and kits useful for treatment of cough

Publications (1)

Publication Number Publication Date
BRPI0819338A2 true BRPI0819338A2 (pt) 2015-05-19

Family

ID=40303655

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0819819-5A BRPI0819819A2 (pt) 2007-11-21 2008-11-20 Preparações, método e kits ùteis para o tratamento de tosse
BRPI0819338-0A BRPI0819338A2 (pt) 2007-11-21 2008-11-20 Preparações, métodos e kits úteis para o tratamento de tosse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0819819-5A BRPI0819819A2 (pt) 2007-11-21 2008-11-20 Preparações, método e kits ùteis para o tratamento de tosse

Country Status (11)

Country Link
US (3) US9149429B2 (pt)
EP (2) EP2219677A1 (pt)
JP (1) JP2011504184A (pt)
CN (2) CN101868253A (pt)
AU (1) AU2008326386B2 (pt)
BR (2) BRPI0819819A2 (pt)
CA (2) CA2706472A1 (pt)
ES (1) ES2655477T3 (pt)
MX (2) MX2010005642A (pt)
RU (1) RU2476240C2 (pt)
WO (2) WO2009066262A1 (pt)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011005032A (es) * 2008-11-13 2011-06-16 Vdf Futureceuticals Inc Composiciones y metodos para aliviar hiposalivacion y para proveer confort oral.
CA2649936A1 (en) 2009-01-15 2010-07-15 John Lawrence Rowe Honey product having a low water content
US20110104081A1 (en) 2009-11-03 2011-05-05 Douglas Craig Scott Oral Compositions for Treatment of Dry Mouth
US20110104080A1 (en) 2009-11-03 2011-05-05 David Salloum Salloum Oral Compositions for Treatment of Dry Mouth
US20110195042A1 (en) * 2010-02-10 2011-08-11 Thomas Edward Huetter Compositions, Methods and Kits Useful for Treating a Respiratory Symptom
US10085938B2 (en) * 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US9987224B2 (en) * 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
JP2014518555A (ja) 2011-04-19 2014-07-31 アームズ ファーマシューティカル エルエルシー 有害な微生物を阻害する方法及びそのためのバリア形成組成物
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
KR101915056B1 (ko) * 2012-04-10 2018-11-07 한미약품 주식회사 암브록솔, 레보드로프로피진 및 완충제를 포함하는 경구용 액상 제제 및 이의 제조방법
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions
DE202013000445U1 (de) * 2012-10-04 2013-10-07 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung, insbesondere pharmazeutische Zusammensetzung, insbesondere zur Verabreichung bei Heiserkeit
RS56980B1 (sr) * 2012-10-18 2018-05-31 Montero Gida Sanayi Ve Ticaret As Biljne formulacije
PL2908834T3 (pl) * 2012-10-18 2017-12-29 Montero Gida Sanayi Ve Ticaret A.S. Nowe preparaty zawierające wyciągi roślinne
EP2941255A4 (en) * 2013-01-04 2016-07-06 ARMS Pharmaceutical LLC Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
MX361099B (es) 2013-02-13 2018-11-27 Procter & Gamble Medicamento con sabor a anís.
US20140294990A1 (en) * 2013-03-27 2014-10-02 Timothy P. O'Connor Throat gargle tablet and method of use thereof
CN103432029B (zh) * 2013-08-15 2016-02-17 金红叶纸业集团有限公司 组合物及应用其的纸巾
ITRM20130592A1 (it) * 2013-10-25 2015-04-26 Aboca Spa Societa Agricola Composizione per la tosse.
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
CN103875802B (zh) * 2014-04-15 2015-04-08 厦门绿链集成服务有限公司 一种新鲜水果的保鲜方法
CN107028987A (zh) * 2017-04-11 2017-08-11 成都吉氧屋科技有限公司 一种微生物黏附率调节剂及其应用
US11007171B2 (en) * 2017-07-13 2021-05-18 Summit Innovation Labs, LLC Treatment and prevention of joint disorders
FR3074688B1 (fr) 2017-12-13 2020-07-10 Roquette Freres Systeme epaississant et stabilisant d'origine naturelle convenant notamment a la preparation de produits cosmetiques
US20220040097A1 (en) * 2018-06-21 2022-02-10 Genexa Inc. Chewable tablet
US11273123B2 (en) 2018-07-18 2022-03-15 USpharma Ltd Chewable pharmaceutical dosage forms
US12390416B2 (en) 2018-07-18 2025-08-19 USpharma Ltd Chewable pharmaceutical dosage forms
US12343345B2 (en) 2018-10-22 2025-07-01 Cmpd Licensing, Llc Non-infective nasal symptom management compositions and methods
US20220047627A1 (en) * 2018-10-22 2022-02-17 Cmpd Licensing, Llc Non-infective nasal symptom management compositions and methods
US20220062173A1 (en) * 2019-01-08 2022-03-03 Johnson & Johnson Consumer Inc. Liquid compositions
CN112439072A (zh) * 2019-08-29 2021-03-05 鲁南制药集团股份有限公司 一种掩味组合物及其制备方法、用途
CN116726054B (zh) * 2022-12-05 2024-03-26 山东新时代药业有限公司 一种即食型益生菌组合物及其制备方法、用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1121358A (en) * 1965-10-21 1968-07-24 Bristol Myers Co Aerosol manufacture
US4029797A (en) * 1973-06-20 1977-06-14 Fisons Corporation Process of making cough syrup with masked noscapine
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
ES2033464T3 (es) 1987-09-04 1993-03-16 The Procter & Gamble Company Composiciones de relleno que contienen psyllium.
ATE92276T1 (de) 1989-03-16 1993-08-15 Procter & Gamble Psyllium enthaltende kekse mit hohem fasergehalt.
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
US5296209A (en) 1992-01-17 1994-03-22 Colgate Palmolive Company Pet chew product having oral care properties
NO941358L (no) * 1993-04-16 1994-10-17 Mcneil Ppc Inc Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav
US5458879A (en) 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
WO1996021432A1 (en) * 1995-01-11 1996-07-18 Cygnus, Inc. Delivery of active substances by way of mucosal surfaces of pharyngeal and esophageal regions
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
WO1996039116A1 (en) * 1995-06-05 1996-12-12 Whitehill Oral Technologies, Inc. Oral care ultramulsion based products
FR2741535B1 (fr) * 1995-11-28 1998-12-24 Sun Trading Ltd Nouvelles preparations pour la sphere bucco-pharyngee
FR2757022B1 (fr) * 1996-12-13 1999-03-05 Bel Fromageries Nouveau procede d'enrobage pour produits alimentaires et les produits enrobes obtenus
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
GB2328443B (en) * 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
US6599883B1 (en) 1998-10-30 2003-07-29 Nastech Pharmaceutical Company, Inc. Nasal delivery of xylitol
GB9827355D0 (en) * 1998-12-11 1999-02-03 Biochemie Sa Organic compounds
IN186667B (pt) 1999-01-29 2001-10-20 Ajanta Pharma Ltd
US6230052B1 (en) * 1999-01-29 2001-05-08 Andy Wolff Device and method for stimulating salivation
AU5208401A (en) * 2000-04-28 2001-11-12 Inflazyme Pharm Ltd 3-nitrogen-6,7-dioxygen steroids and uses related thereto
CA2445973C (en) * 2001-04-30 2012-06-26 Ben Milam Meager Device for creating a seal between fabrics or other materials
US6696047B2 (en) * 2001-09-13 2004-02-24 The Procter & Gamble Company Stable oral care compositions comprising chlorite
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
US20030170371A1 (en) 2002-01-10 2003-09-11 Cargill, Inc. High fat/fiber composition
US20050214349A1 (en) 2002-10-30 2005-09-29 Li Nie Extruded gluten based pet chew bodies
US20060193959A1 (en) 2002-10-30 2006-08-31 Li Nie Low calorie injection molded starch-based pet chew bodies
DE10253331A1 (de) * 2002-11-14 2004-06-03 Symrise Gmbh & Co. Kg Verwendung von trans-Pellitori als Aromastoff
MXPA05005243A (es) * 2002-11-14 2006-03-10 Innozen Inc Pelicula comestible para el alivio de la tos o sontomas relacionados con la faringitis.
DE10261061A1 (de) 2002-12-24 2004-07-15 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätetisches Lebensmittel zur positiven Beeinflussung der kardiovaskulären Gesundheit
JP2006514077A (ja) 2003-01-13 2006-04-27 ザ プロクター アンド ギャンブル カンパニー 選抜された粘膜付着性ポリマーを含む、感冒及びインフルエンザ様の症状の予防及び治療のための組成物
WO2004084637A1 (en) 2003-03-24 2004-10-07 Council Of Scientific And Industrial Research A high fibre biscuit composition and a process for preparing the same
MXPA05013049A (es) * 2003-06-05 2006-09-04 Cooperatie Avebe U A Almidones pregelatinizados dispersables instantaneamente para uso en productos alimenticios.
US7118772B2 (en) 2003-09-18 2006-10-10 General Mills, Inc. Inulin infused fruit and method of preparation
CN1905799A (zh) 2003-11-07 2007-01-31 Mgp配料有限公司 制造高蛋白和低碳水化合物食品的组合物及方法
US20060039973A1 (en) 2004-08-19 2006-02-23 Mary Aldritt Effervescent composition including water soluble dietary fiber
US20060120967A1 (en) * 2004-12-07 2006-06-08 Qpharma, Llc Solution forms of cyclodextrins for nasal or throat delivery of essential oils
US20060188450A1 (en) * 2005-02-24 2006-08-24 Tim Clarot System and method for suppressing a cough
US20070042023A1 (en) * 2005-08-22 2007-02-22 National Starch And Chemical Investment Holding Corporation Dissolvable film
US20070048424A1 (en) * 2005-09-01 2007-03-01 Moza Ashok K Liquid composition of 2-Isopropyl-N,2,3-trimethylbutyramide and N-Ethyl-p-menthane-3-carboxamide, its preparation method and its applications as a cooling agent and flavor enhancer
US20070148283A1 (en) 2005-12-23 2007-06-28 Cadbury Adams Usa Llc Compositions providing a sensation substantially similar to that provided by menthol
US20070178123A1 (en) 2006-01-27 2007-08-02 Deborah Levenson Flavor-enhancing compositions, method of manufacture, and methods of use
US9005652B2 (en) 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine

Also Published As

Publication number Publication date
CN101868253A (zh) 2010-10-20
CA2706440C (en) 2014-03-25
MX2010005643A (es) 2010-07-30
WO2009067605A2 (en) 2009-05-28
US20090155189A1 (en) 2009-06-18
EP2219677A1 (en) 2010-08-25
MX337194B (es) 2016-02-15
AU2008326386B2 (en) 2014-07-31
US20160000925A1 (en) 2016-01-07
EP2217279A2 (en) 2010-08-18
WO2009067605A3 (en) 2010-02-11
ES2655477T3 (es) 2018-02-20
EP2217279B1 (en) 2017-11-01
BRPI0819819A2 (pt) 2015-05-26
US20090130199A1 (en) 2009-05-21
RU2010116996A (ru) 2011-12-27
US9149429B2 (en) 2015-10-06
CA2706440A1 (en) 2009-05-28
MX2010005642A (es) 2010-07-30
CN101868252A (zh) 2010-10-20
RU2476240C2 (ru) 2013-02-27
CA2706472A1 (en) 2009-05-28
JP2011504184A (ja) 2011-02-03
WO2009066262A1 (en) 2009-05-28
AU2008326386A1 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
BRPI0819338A2 (pt) Preparações, métodos e kits úteis para o tratamento de tosse
BRPI0809573A8 (pt) composição, e, método
FI20075269A0 (fi) Menetelmä ja järjestely antennin sovittamiseksi
BRPI0817292A2 (pt) Método e aparelho para completação de poços.
CY2016005I2 (el) Αλκαλικη φωσφαταση στοχευμενη στα οστα, κιτ και μεθοδοι χρησης αυτων
BRPI0923159A2 (pt) gene de delta-endotoxina axmi-150 e métodos para sua utilização.
BRPI0821276A2 (pt) Produto, e, uso do produto
IL191759A (en) Ganaxolone formulations and methods for the making and use thereof
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0814330A2 (pt) métodos e kits cirúrgicos
BRPI0820556A2 (pt) Bactéria e métodos para uso das mesmas
BRPI0919575A2 (pt) método, e, composição
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
FI20075978A0 (fi) Järjestely ja menetelmä
BRPI0815887A2 (pt) Uso de conduto metálico, processo e duto subterrâneo.
BRPI0816063A2 (pt) Garrafas retráteis e métodos para uso do mesmo
BRPI0813969A2 (pt) Método para tingir permanentemente o cabelo, e, kit para tingir em substrato queratinoso.
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
FI20065348L (fi) Spektrometri ja inferferometrinen menetelmä
BR112012000735A2 (pt) "métodos, kits e conjuntos de compostos"
BRPI0823277A2 (pt) Composição, e , método
BRPI0822296A2 (pt) Transponder e livreto
BRPI0814167A2 (pt) Composição, e, método
PT2868315T (pt) Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos
BRPI0921960A2 (pt) granulado de pigmento, método para produzir o mesmo e uso do mesmo

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.